CN102614324A - Chinese medicinal synthetic preparation for assisting western medicines in treating phlebophlogosis - Google Patents
Chinese medicinal synthetic preparation for assisting western medicines in treating phlebophlogosis Download PDFInfo
- Publication number
- CN102614324A CN102614324A CN2012101234125A CN201210123412A CN102614324A CN 102614324 A CN102614324 A CN 102614324A CN 2012101234125 A CN2012101234125 A CN 2012101234125A CN 201210123412 A CN201210123412 A CN 201210123412A CN 102614324 A CN102614324 A CN 102614324A
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- chinese medicinal
- chinese
- synthetic preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a Chinese medicinal preparation, in particular to a Chinese medicinal synthetic preparation for assisting western medicines in treating phlebophlogosis. The Chinese medicinal synthetic preparation consists of the following Chinese herbal medicines by weight: 15 grams of red paeony root, 15 grams of cortex moutan, 30 grams of Sinkiang arnebia root, 15 grams of Chinese angelica, 30 grams of Mongolian dandelion herb, 30 grams of philippine violet herb, 30 grams of lonicera flower, 30 grams of wild chrysanthemum flower, 10 grams of rhubarb and 15 grams of lightyellow sophora root. The red paeony root, the cortex moutan, the Sinkiang arnebia root, the Chinese angelica, the Mongolian dandelion herb, the philippine violet herb, the lonicera flower, the wild chrysanthemum flower, the rhubarb and the lightyellow sophora root are ground into fine powder, and the fine powder is blended uniformly by using proper amount of vinegar to form paste. According to the Chinese medicinal synthetic preparation, due to the adoption of a mode of combined treatment of Chinese medicines and the western medicines, a treatment effect is obvious; and the Chinese medicinal synthetic preparation also can act on a part above the transfusion positions of patients directly, an obvious curative effect is achieved, phlebophlogosis is prevented effectively, and the pain of the patients is relieved, so the Chinese medicinal synthetic preparation has a good effect of adjuvant therapy on transfusion phlebophlogosis, and has the advantages of promoting blood circulation to remove blood stasis, clearing heat and removing toxicity, promoting the elimination of inflammation and the like.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation, the phlebitic Chinese medicine synthesising preparation of a kind of specifically auxiliary western medicine.
Background technology
Phlebitis is one of most common complication in the venous transfusion therapeutic process, and clinical manifestation red line occurs for the puncture vein redness and pain occur along the vein trend under the skin, and the severe patient vein rope strip can occur and change and tuberosity.Phlebitis has not only increased patient's misery, has also influenced therapeutic effect simultaneously.It mainly is owing to medicine that same radicular vein repeated multiple times punctures or input concentration is higher, zest is stronger or the bigger oversize chemical inflammatory reaction that causes local wall of vein of plastic tube time of intravenous indwelling zest, and generation is often arranged clinically.Prevention phlebitis is to medical safety and to alleviate the patient suffering significant.
Motherland's medical science thinks, red, swollen, burning pain is due to the pyretic toxicity, and phlebitis is that puncture injures local venation hematogenous blockage and causes the blood stasis resistance that stagnates in the infusion process, and " stagnation of QI and blood may bring about pain " QI-blood circulation is smooth, the defeated cloth of body fluid is obstructed causes distending pain; Meridians are impaired, qi depression to blood stasis, and meridians are not smooth, so streak line and scleroma are arranged; Accumulate in the blood stasis, accumulate heat-transformation of a specified duration, then local pyrexia; The venation damage is accumulate then local rubescent swollen hard in blood oozing from the body openings or subcuta neous tissue skin or the heat in blood.Its genesis mechanism is that QI and blood is retarded by silt, and pyretic toxicity stagnates in blood vessels, makes local venation QI-blood circulation not smooth.Controlling should blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing and reach reducing swelling and alleviating pain.
It is relevant with multiple factor that doctor trained in Western medicine thinks that primary disease takes place, and the common origin cause of formation is following:
Pharmaceutical properties---commonly bring out phlebitic medicine and comprise antibiotic, antineoplastic chemotherapy medicine, hyperosmosis medicine etc.Drug osmotic is pressed high more, and is big more to the venous stimulation.Chemotherapeutics has stimulation in various degree to vein blood vessel, and general drug level is high more, then the holdup time in local vascular long more, the phlebitis incidence rate is high more.
Particle contamination---particle contamination is one of major incentive of transfusion induced phlebitis.Transfusion particle pollutes by way of comprising infusion set, dosing operation and air pollution.In addition, unreasonable compatibility of drugs also can cause particulate matter multiplication in the transfusion, and particle number is proportionate in research proof compatibe drug number and the transfusion, and particularly powder ampoule agent for injection, Chinese medicine add transfusion back particle number significantly increases.
Site of puncture---site of puncture blood vessels caliber and phlebitis incidence rate significant correlation, blood vessels caliber is more little, and the phlebitis probability of happening is high more.In addition, lower limb are many and VPV is slower because of venous valve, so be prone to generation phlebitis.Therefore, venous transfusion should be followed the principle of avoiding selecting to suffer from limb or lower limb vascular transfusion.
Fuselage state---Abwehrkraft des Koepers is low, and especially phlebitis very easily takes place in the infusion treatment process people of skin mucosa defence capability decline.
Summary of the invention
The phlebitic Chinese medicine synthesising preparation of auxiliary western medicine that the purpose of this invention is to provide a kind of blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, promotion inflammatory resolution.
The technical solution adopted for the present invention to solve the technical problems is:
The phlebitic Chinese medicine synthesising preparation of a kind of auxiliary western medicine; It is characterized in that raw material medicaments in part by weight is made up of Radix Paeoniae Rubra 15 gram, Cortex Moutan 15 grams, Radix Arnebiae (Radix Lithospermi) 30 grams, Radix Angelicae Sinensis 15 grams, Herba Taraxaci 30 grams, Herba Violae 30 grams, Flos Lonicerae 30 grams, Flos Chrysanthemi Indici 30 grams, Radix Et Rhizoma Rhei 10 grams and Radix Sophorae Flavescentis 15 grams; Above-mentioned Radix Paeoniae Rubra, Cortex Moutan, Radix Arnebiae (Radix Lithospermi), Radix Angelicae Sinensis, Herba Taraxaci, Herba Violae, Flos Lonicerae, Flos Chrysanthemi Indici, Radix Et Rhizoma Rhei, Radix Sophorae Flavescentis pulverization are in harmonious proportion evenly, with an amount of vinegar furnishing pasty state.
Side of the present invention separates:
The Radix Paeoniae Rubra bitter in the mouth is slightly cold.Return Liver Channel.Effect clearing away heat and cooling blood, eliminating stasis to stop pain, purging liver-fire.Cortex Moutan: bitter in the mouth, suffering are slightly cold.GUIXIN, liver, kidney channel.Cortex Moutan effect clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling.The Radix Arnebiae (Radix Lithospermi) sweet in the mouth, cold in nature.GUIXIN, Liver Channel.Effect removing heat from blood and promoting blood circulation, detoxifcation rash.Radix Angelicae Sinensis: sweet in the mouth, suffering, warm in nature.Return liver, the heart, spleen channel.Effect is enriched blood and is invigorated blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation.Herba Taraxaci: bitter in the mouth, sweet, cold in nature.Return liver, stomach warp.Effect heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation, inducing diuresis for treating stranguria syndrome.Herba Violae: bitter in the mouth, suffering, cold in nature.GUIXIN, Liver Channel.The effect heat-clearing and toxic substances removing.Heat clearing away, detumescence and antiinflammation are arranged.The Flos Lonicerae sweet in the mouth, cold in nature.Return lung, the heart, stomach warp.Effect heat-clearing and toxic substances removing, dispelling wind and heat pathogens.Flower has antiinflammatory, analgesic, anti-allergic effects.Flos Chrysanthemi Indici: acrid in the mouth, sweet, bitter, cold nature.Return lung, Liver Channel.Effect dispelling wind and heat pathogens, suppressing the hyperactive liver make eye bright, heat-clearing and toxic substances removing.Flos Chrysanthemi has the resisting pathogenic microbes effect.In vitro tests shows that these article water decoction and water logging agent have inhibitory action to various pathogens, influenza virus PR8 and leptospira; Radix Et Rhizoma Rhei: bitter in the mouth, cold in nature.Return spleen, stomach, large intestine, liver, pericardium channel.Effect purging heat and dredging bowels, removing pathogenic heat from blood and toxic substance from the body, eliminating blood stasis and inducing menstruation.The Radix Sophorae Flavescentis bitter in the mouth, cold in nature.GUIXIN, liver, stomach, large intestine, urinary bladder channel.Effect heat clearing and damp drying, wind dispelling insecticide, diuresis, leukorrhagia stopping.Radix Sophorae Flavescentis has the resisting pathogenic microbes effect.All there is antibacterial action the matrine inside and outside.All medicines share, blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, and with vinegar as excipient; Vinegar is the very important adjuvant of the traditional Chinese medical science, can not only the effective ingredient of medicine be dissolved out, and is easy to absorption of human body; The position that can also need treatment so as to the arrival of guiding drug effect; Have sterilization, antibacterial, antidotal effect simultaneously, promote inflammatory resolution, reach the purpose of treatment.
Taboo: allergy sufferers forbidding.
During use, the oral antihistamines loratadine spreads on patient's phlebitis place with the synthesising preparation of furnishing pasty state simultaneously and takes off after 3 hours, applies 1 week of continuous application in second day again.
The present invention is owing to adopt collaborative treatment of Chinese and western medicines; Therapeutic effect is remarkable, and the present invention also can directly locate drug effect in the patient infusion top, evident in efficacy; The effectively phlebitic generation of prevention; Alleviating patient's misery, is that good auxiliary treatment effect is arranged to the transfusion induced phlebitis, has advantages such as blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, promotion inflammatory resolution.
The specific embodiment
Present embodiment: use following raw materials in weight portion medicine to process mixture to be:
Get clean Radix Paeoniae Rubra 15 grams, Cortex Moutan 15 grams, Radix Arnebiae (Radix Lithospermi) 30 grams, Radix Angelicae Sinensis 15 grams, Herba Taraxaci 30 grams, Herba Violae 30 grams, Flos Lonicerae 30 grams, Flos Chrysanthemi Indici 30 grams, Radix Et Rhizoma Rhei 10 grams, Radix Sophorae Flavescentis 15 grams; After medicine assorted; Be in harmonious proportion and evenly also process mixture, get above-mentioned mixture and get final product with an amount of vinegar furnishing pasty state with the medical instrument pulverization.During use, first oral western medicine antihistaminic loratadine spreads on patient's phlebitis place with the synthesising preparation of furnishing pasty state simultaneously and takes off after 3 hours, and second day repeats above-mentioned steps, 1 week of continuous application.
Side of the present invention separates: the Radix Paeoniae Rubra bitter in the mouth is slightly cold.Return Liver Channel.Effect clearing away heat and cooling blood, eliminating stasis to stop pain, purging liver-fire.Cortex Moutan: bitter in the mouth, suffering are slightly cold.GUIXIN, liver, kidney channel.Cortex Moutan effect clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling.The Radix Arnebiae (Radix Lithospermi) sweet in the mouth, cold in nature.GUIXIN, Liver Channel.Effect removing heat from blood and promoting blood circulation, detoxifcation rash.Radix Angelicae Sinensis: sweet in the mouth, suffering, warm in nature.Return liver, the heart, spleen channel.Effect is enriched blood and is invigorated blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation.Herba Taraxaci: bitter in the mouth, sweet, cold in nature.Return liver, stomach warp.Effect heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation, inducing diuresis for treating stranguria syndrome.Herba Violae: bitter in the mouth, suffering, cold in nature.GUIXIN, Liver Channel.The effect heat-clearing and toxic substances removing.Heat clearing away, detumescence and antiinflammation are arranged.The Flos Lonicerae sweet in the mouth, cold in nature.Return lung, the heart, stomach warp.Effect heat-clearing and toxic substances removing, dispelling wind and heat pathogens.Flower has antiinflammatory, analgesic, anti-allergic effects.Flos Chrysanthemi Indici: acrid in the mouth, sweet, bitter, cold nature.Return lung, Liver Channel.Effect dispelling wind and heat pathogens, suppressing the hyperactive liver make eye bright, heat-clearing and toxic substances removing.Flos Chrysanthemi has the resisting pathogenic microbes effect.In vitro tests shows that these article water decoction and water logging agent have inhibitory action to various pathogens, influenza virus PR8 and leptospira; Radix Et Rhizoma Rhei: bitter in the mouth, cold in nature.Return spleen, stomach, large intestine, liver, pericardium channel.Effect purging heat and dredging bowels, removing pathogenic heat from blood and toxic substance from the body, eliminating blood stasis and inducing menstruation.The Radix Sophorae Flavescentis bitter in the mouth, cold in nature.GUIXIN, liver, stomach, large intestine, urinary bladder channel.Effect heat clearing and damp drying, wind dispelling insecticide, diuresis, leukorrhagia stopping.Radix Sophorae Flavescentis has the resisting pathogenic microbes effect.All there is antibacterial action the matrine inside and outside.All medicines share, blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, and with vinegar as excipient; Vinegar is the very important adjuvant of the traditional Chinese medical science, can not only the effective ingredient of medicine be dissolved out, and is easy to absorption of human body; The position that can also need treatment so as to the arrival of guiding drug effect; Have sterilization, antibacterial, antidotal effect simultaneously, promote inflammatory resolution, reach the purpose of treatment.
Below in conjunction with clinical trial the present invention is done further, describes in detail:
1 case is selected: this organizes 100 examples, male 52 examples, and women 48 examples, at 18 years old to 70 years old age, all case all is the patient of transfusion induced phlebitis, the course of disease is 3 to 10 years.
2 Therapeutic Method: this group patient is divided into two groups, treatment group and matched group, every group of each 50 example are after medicine assorted; Pulverization with an amount of vinegar furnishing pasty state, spreads on treatment group patient affected part and takes off after 3 hours; Applied in second day, be 1 week a course of treatment again, with 2-3 the course of treatment; Treatment adds simultaneously takes the antihistaminic loratadine, once a day, and each 10mg.Matched group is taken Western medicine antihistaminic loratadine, once a day, and each 10mg.
3 therapeutic effect: use the present invention to treat 50 examples altogether, total effective rate is 100% as a result; The matched group effective percentage is 60%.
4 model cases: patient Li Ping to my institute's inspection, is diagnosed as the transfusion induced phlebitis; Get 10 milligrams of antihistaminic loratadines, Radix Paeoniae Rubra 15 grams, Cortex Moutan 15 grams, Radix Arnebiae (Radix Lithospermi) 30 grams, Radix Angelicae Sinensis 15 grams, Herba Taraxaci 30 grams, Herba Violae 30 grams, Flos Lonicerae 30 grams, Flos Chrysanthemi Indici 30 grams, Radix Et Rhizoma Rhei 10 grams and Radix Sophorae Flavescentis 15 grams, after medicine is assorted, above-mentioned Radix Paeoniae Rubra, Cortex Moutan, Radix Arnebiae (Radix Lithospermi), Radix Angelicae Sinensis, Herba Taraxaci, Herba Violae, Flos Lonicerae, Flos Chrysanthemi Indici, Radix Et Rhizoma Rhei and Radix Sophorae Flavescentis are in harmonious proportion evenly and process mixture with the medical instrument pulverization; Get above-mentioned mixture with an amount of vinegar furnishing pasty state; During use, 10 milligrams of first oral antihistamines loratadines spread on patient's phlebitis place with the synthesising preparation of furnishing pasty state simultaneously and take off after 3 hours; Second day sx; Continue the repetition above-mentioned steps, 1 week of continuous application, symptom complete obiteration.
Taboo: allergy sufferers forbidding.
The present invention is owing to adopt collaborative treatment of Chinese and western medicines; Therapeutic effect is remarkable, and the present invention also can directly locate drug effect in the patient infusion top, evident in efficacy; The effectively phlebitic generation of prevention; Alleviating patient's misery, is that good auxiliary treatment effect is arranged to the transfusion induced phlebitis, has advantages such as blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, promotion inflammatory resolution.。
Claims (1)
1. phlebitic Chinese medicine synthesising preparation of auxiliary western medicine; It is characterized in that raw material medicaments in part by weight is made up of Radix Paeoniae Rubra 15 gram, Cortex Moutan 15 grams, Radix Arnebiae (Radix Lithospermi) 30 grams, Radix Angelicae Sinensis 15 grams, Herba Taraxaci 30 grams, Herba Violae 30 grams, Flos Lonicerae 30 grams, Flos Chrysanthemi Indici 30 grams, Radix Et Rhizoma Rhei 10 grams and Radix Sophorae Flavescentis 15 grams; Above-mentioned Radix Paeoniae Rubra, Cortex Moutan, Radix Arnebiae (Radix Lithospermi), Radix Angelicae Sinensis, Herba Taraxaci, Herba Violae, Flos Lonicerae, Flos Chrysanthemi Indici, Radix Et Rhizoma Rhei, Radix Sophorae Flavescentis pulverization are in harmonious proportion evenly, with an amount of vinegar furnishing pasty state.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101234125A CN102614324A (en) | 2012-04-25 | 2012-04-25 | Chinese medicinal synthetic preparation for assisting western medicines in treating phlebophlogosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101234125A CN102614324A (en) | 2012-04-25 | 2012-04-25 | Chinese medicinal synthetic preparation for assisting western medicines in treating phlebophlogosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102614324A true CN102614324A (en) | 2012-08-01 |
Family
ID=46554773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012101234125A Pending CN102614324A (en) | 2012-04-25 | 2012-04-25 | Chinese medicinal synthetic preparation for assisting western medicines in treating phlebophlogosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102614324A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104225526A (en) * | 2014-08-28 | 2014-12-24 | 王萍 | Traditional Chinese medicinal composition for treating skin bruising after transfusion |
| CN105147726A (en) * | 2015-09-25 | 2015-12-16 | 尹楠楠 | Medical application preventing and curing phlebitis and preparing method thereof |
| CN113967229A (en) * | 2020-07-22 | 2022-01-25 | 上海图锋医药科技有限公司 | Traditional Chinese medicine composition and preparation method and application thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101683441A (en) * | 2008-09-23 | 2010-03-31 | 天津市中宝制药有限公司 | Traditional Chinese medicine composition for invigorating blood circulation and dissolving stasis |
-
2012
- 2012-04-25 CN CN2012101234125A patent/CN102614324A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101683441A (en) * | 2008-09-23 | 2010-03-31 | 天津市中宝制药有限公司 | Traditional Chinese medicine composition for invigorating blood circulation and dissolving stasis |
Non-Patent Citations (4)
| Title |
|---|
| 《内蒙古中医药》 20080131 王翠莲 "血栓性静脉炎的中医药治疗概况" , 第1期 * |
| 《护理研究》 20070930 乔雨晨 "中草药治疗静脉炎的研究进展" 第21卷, 第9期 * |
| 乔雨晨: ""中草药治疗静脉炎的研究进展"", 《护理研究》, vol. 21, no. 9, 30 September 2007 (2007-09-30) * |
| 王翠莲: ""血栓性静脉炎的中医药治疗概况"", 《内蒙古中医药》, no. 1, 31 January 2008 (2008-01-31) * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104225526A (en) * | 2014-08-28 | 2014-12-24 | 王萍 | Traditional Chinese medicinal composition for treating skin bruising after transfusion |
| CN105147726A (en) * | 2015-09-25 | 2015-12-16 | 尹楠楠 | Medical application preventing and curing phlebitis and preparing method thereof |
| CN113967229A (en) * | 2020-07-22 | 2022-01-25 | 上海图锋医药科技有限公司 | Traditional Chinese medicine composition and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102614440B (en) | Multi-herb antibacterial liquid | |
| CN101637585A (en) | Chinese herbal preparation for treating posirasis and preparation method thereof | |
| CN101391015A (en) | External traditional Chinese medicine powder for treating recurrent hemorrhoid | |
| CN102526677A (en) | Chinese medicine foot-massage composition for treating common cold due to wind-cold | |
| CN101843694A (en) | Chinese medicament for treating chronic hepatitis | |
| CN100444888C (en) | The Chinese herbal medicinal pills for treatment of hepatitis B and liver cancer | |
| CN102614324A (en) | Chinese medicinal synthetic preparation for assisting western medicines in treating phlebophlogosis | |
| CN111298053A (en) | Bezoar dragon bone ointment for treating hemorrhoid | |
| CN104027514A (en) | Traditional Chinese medicine used for treating acute cholecystitis | |
| CN104689132A (en) | Traditional Chinese medicine composition for treating psoriasis | |
| CN104027522A (en) | Traditional Chinese medicament for treating acute appendicitis | |
| CN103893701B (en) | A kind of Chinese medicine composition alleviating patients suffering from postoperative pain and promote wound healing | |
| CN104800427A (en) | Burn and scald recovery application and preparation method thereof | |
| CN104524432A (en) | Traditional Chinese medicine for treating liver and gallbladder damp-heat-type gallstone | |
| CN103768328A (en) | Medicinal magnetic plaster for treating tumors | |
| CN115887601B (en) | A composition for treating hemorrhoid and its preparation method | |
| CN113491739B (en) | Pain-relieving and stasis-eliminating traditional Chinese medicine for treating endometriosis and preparation method thereof | |
| CN114246893B (en) | Traditional Chinese medicine external preparation for treating depigmentation and preparation method and application thereof | |
| CN102114211A (en) | Chinese herbal medicine for treating hepatopathy | |
| CN101439163B (en) | Chinese medicine for radically treating hemorrhoid | |
| CN101288760B (en) | Externally-used drug for treating appendicitis | |
| CN1283282C (en) | Chinese traditional medicine for treating appendicitis | |
| CN101450133A (en) | Medicine for treating abdominopelvic cavity disease postoperative intestinal adhesion | |
| CN105456447A (en) | Folium artemisiae argyi-containing traditional Chinese medicine composition with function of promoting blood circulation to remove stasis and preparation method thereof | |
| CN105012470A (en) | Medicine liquor for treating cervical cancer complication radiation proctitis through coloclysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120801 |